WGC De Bruggen
- Address
- Sint-Pietersnoordstraat 40A, 8000 Bruges, Belgium
WGC De Bruggen - Primary Care Research Center
WGC De Bruggen is a primary care research center specializing in medication optimization and deprescribing strategies. The center focuses on improving patient care through evidence-based approaches to long-term medication management, with particular emphasis on proton pump inhibitor (PPI) therapy and gastrointestinal conditions commonly managed in primary care settings.
- Deprescribing strategies for chronic medication use
- Proton pump inhibitor optimization and alternatives
- Heartburn and gastrointestinal symptom management
The center conducts innovative comparative effectiveness research evaluating different therapeutic approaches, including on-demand medication strategies and alginate formulations as alternatives to chronic PPI use. Their work aims to identify optimal deprescribing methods for patients on long-term PPI therapy without established indications, addressing an important issue in primary care where medication overuse is a growing concern.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in WGC De Bruggen
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients: impact of on-demand use, adjustment of therapy or discontinuation. | UZ Leuven | Phase III | Not Recruiting | Apr 2023 | Mar 2026 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aluminium Oxide | 1 | Unknown | 2023-04-16 | 2023-04-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.